ReleaseWire

Transparency Market Research (TMR) has published a new report titled, "Thalassemia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026". According to the report, the global thalassemia treatment market was valued at US$ 842.0 Mn in 2017 and is projected to expand at a CAGR of 7.9% from 2018 to 2026. Increase in R&D investment by key players for developing new drugs for treating thalassemia and rise in demand for chelating therapy are anticipated to fuel the growth of the global market from 2018 to 2026.

Antiviral drugs are a class of medication that inhibits the development of infection causing viruses. Like antibiotics, specific antiviral drugs are used against specific viruses. As viruses share most of the metabolic processes with the host cell, it is difficult to commercialize new medications that are selective in action. The presently available antiviral agents either act as DNA polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors, immunomodulators, neuraminidase inhibitors or integrase strand transfer inhibitors.

Body contouring process helps in altering the shape of human body to make it look appealing. In the process, the excessive skin from various parts such as thighs, upper arms, torso, chest, buttocks are grafted on face. This surgery is more beneficial for the ones who have undergone a weight loss and is looking to get excess skin removed along with the remaining fats from the body. There are several processes of body contouring such as bra line back lift, implants, body lift, body fat transfer, and abdominal etching. The process is very common among the people who want to improve or remove their sagging skin and excess fat.

Refurbished medical imaging equipment are restored to the original specification when these were purchased new. Medical imaging equipment are refurbished in two ways; cosmetic refurbishment and mechanical-electrical refurbishment. The cosmetic refurbishment process includes painting and surface treatment. The electrical-mechanical refurbishment process comprises complete restoration of the equipment, including parts and other critical components. The refurbishment process is validated and accepted through various governing bodies such as COCIR, NEMA, and International Association of Medical Equipment Remarketers and Servicers (IAMERS). In 2017, the global refurbished medical imaging equipment market was valued at US$ 903.2 Mn and is projected to expand at a CAGR of 5.4% from 2018 to 2026.

The healthcare information systems market has progressed from being in a nascent phase in the 80s to a thriving market in recent years due to quicker adoption rates of healthcare information systems and demand for them from large as well as smaller health care organizations. Digitization of health care records has created a far more informed, innovative, and personalized care paradigm. Digitized records enable physicians to recognize warning signs for individuals who are on the edge of major health issues, thus preventing expensive treatments and hospitalizations. Health care information technology has been shown to improve the quality to care management by enhancing disease surveillance, increasing adherence to guidelines, and decreasing medication error. The global health care information systems market has expanded rapidly over the years, and there has been a noticeable rise in adoption of health care information systems in recent times. Continued increase in the cost of health care over the last few years has forced health care institutions to adopt health care IT systems in order to cut costs. About 30% of the health care costs arise due to clinical insufficiencies. The global health care information systems market was valued at US$ 227,021.4 Mn in 2017 and is anticipated to reach US$ 521,682.6 Mn in 2026.

Anal fistula is a tunnel or tract between the epithelial surface of the rectum or anus and the skin i.e., perianal area. This tract can develop infection causing swelling, pus, and pain. The global anal fistula treatment market was valued at US$ 550 Mn in 2017 and is anticipated to expand at a CAGR of 4% from 2018 to 2026 to reach US$ 800 Mn by 2026. High incidence rate of anal fistula and recurrence rate of treated cases have led to a large patient pool. Moreover, increase in incidence of anal fistula inducing co-morbidities such as Crohn's disease, anal abscess, HIV, and TB infections have resulted in new complex anal fistula cases. Rise in demand for safe and effective treatment with no chance of recurrence and fewer side effects is inducing key industry players to introduce advanced drugs and devices. These include under trial collagen paste for blocking and removing fistula tract, adipose stem cell therapy for anal fistula treatment in Crohn's disease, video-assisted anal fistula treatment (VAAFT) devices, and laser energy-based devices for anal fistula. However, high cost of treatment and lack of awareness about anal fistula treatment are likely to restrain the global anal fistula treatment market during the forecast period.

Fecal occult blood test (FOBT) is a diagnostic screening test used to analyze hidden (occult) blood in stool samples. Fecal occult blood test is also commonly known as Hemoccult, Stool Occult Blood, Guaiac Smear Test gFOBT, Immunoassay FOBT, Immunochemical FOB, and iFOBT. These tests are used to detect polyps in the colon or rectum or polyps bleed. Fecal occult blood test is majorly used for screening of colon cancer and analyzing possible causes of unexplained anemia. Colon cancer is large intestine (colon) cancer, which occurs in the lower part of the digestive system. Colon cancer generally arises with a small, benign cluster of cells, known as adenomatous polyps, which result in colon cancer.

Granulocyte colony stimulating factor is referred as stimulating factor 3, which acts to increase production of stem cells and granulocytes. Filgrastim is a granulocyte colony stimulating factor (G-CSF) prepared by recombinant DNA technology and often used in the treatment of low blood neutrophils. It is also frequently used in conditions where lukapheresis with increased white blood cells is observed. Common adverse effects of Filgrastim include joint pain, chest pain, hair loss, and vomiting. Filgrastim is a recombinant form of naturally occurring G-CSF and functions by stimulating neutrophil production. It was approved in the U.S. in 1991 for the treatment low blood neutrophils. The World Health Organization declared Filgrastim in the List of Essential Medicines as safe and most effective medicine. Filgrastim was first discovered by Amgen, Inc. and sold under the brand name Neupogen. Large number of biosimilar companies are engaged in the manufacture and marketing of Filgrastim across the world. Filgrastim costs around US$ 200 in the U.S, around GBP 50 in the U.K., and US$ 100 in developing countries.

Triple lumen catheters are used for administration of hyperosmolar solutions, measuring central venous pressure, hemodialysis, plasmapheresis, and rapid infusion of fluid, among others. Triple lumen catheters is a type of central venous catheter. Central venous catheter is a thin, flexible tube that is placed into the large vein above the heart, usually through a vein in the neck, chest, or arm. Triple lumen catheters are indicated for hemodialysis, apheresis, infusion, central venous pressure monitoring, and high pressure contrast injection. These catheters are available in straight extension and curved extension catheter options and kit, tray (IC Tray) and safety tray (PASS Tray) configurations. Triple lumen catheters have an independent port for blood access and fluid or medication delivery between dialysis treatments. The catheters have a laser-cut side slot to minimize potential for positional occlusion and the likelihood of clot formation by minimizing debris attachment.

Pet cancer therapeutics are novel anti-cancer drugs that have the ability to reduce the effect of cancerous cell. Depending on the type of cancer and its stage, pet cancer therapeutics generally include monotherapy or combination therapy. The ongoing research is mainly focused on the development of novel anticancer drugs (targeted therapy) to improve the efficacy and reduce the side effects of treatment. This has boosted the expansion of the global pet therapeutics market. For instance, as of 2015, research was focused on genetic regulatory mechanisms in canine cells to develop targeted therapies for canine cancer treatment. Furthermore, organizations such as Petco Foundation, Animal Cancer Foundation, PetCure Oncology, and Veterinary Cancer Society are conducting oncology research to develop targeted anti-cancer therapies with minimum side effects. In addition, rise in number of research grants to develop anti-cancer therapies for various cancer treatments is a major factor driving the global pet cancer therapeutics market. For instance, in 2017, the Animal Cancer Foundation (ACF) received a research grant of US$ 1 Mn from the Blue Buffalo Foundation to support oncology research that aimed at studying similarities between naturally occurring cancers in people and pets and finding effective treatment in both species.

This report studies the global Bifunctional Epoxide Hydrolase 2 market status and forecast, categorizes the global Bifunctional Epoxide Hydrolase 2 market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Exceptional abilities of judgment and precision is required for surgical procedures, and to achieve that, visual clarity is paramount. Consequently, physicians across the world depend on their honed skills and smart tools to perform daily practices. Technological advanced has paved way to surgical loupes and cameras that have proven their worth in improving ergonomics of surgeons and medical professionals who undertake invasive surgical procedures.

This report studies the global Dental Implant and Prosthetic market status and forecast, categorizes the global Dental Implant and Prosthetic market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

This report studies the global Diabetes Care Devices & Drugs market status and forecast, categorizes the global Diabetes Care Devices & Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

This report studies the global Wheat Grass Powder market status and forecast, categorizes the global Wheat Grass Powder market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

In this report, the global Wound Care Dressing market is valued at USD million in 2017 and is expected to reach USD million by the end of 2025, growing at a CAGR of % between 2017 and 2025.

This report studies the global Advanced Wound Care Products market status and forecast, categorizes the global Advanced Wound Care Products market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

In this report, the global Zirconium Dental Implants market is valued at USD million in 2017 and is expected to reach USD million by the end of 2025, growing at a CAGR of % between 2017 and 2025.

This report studies the global Air Ambulance market status and forecast, categorizes the global Air Ambulance market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

This report studies the global Aircraft Engine and Equipment market status and forecast, categorizes the global Aircraft Engine and Equipment market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

This report studies the global All Terrain Vehicle market status and forecast, categorizes the global All Terrain Vehicle market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

This report studies the global Auto Leasing market status and forecast, categorizes the global Auto Leasing market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

This report studies the global Automotive Adhesives market status and forecast, categorizes the global Automotive Adhesives market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

The Study Paper on Top key vendors in Isothermal Nucleic Acid Amplification Technology (INAAT) Market includes are Alere, bioMerieux, Chemical, Hologic, Lucigen, QIAGEN, Quidel Corporation, Thermo Fisher Scientific, BD.

The Study Paper on Top key vendors in NASH (Non-alcoholic Steatohepatitis) Biomarkers Market included is GENFIT SA, Gilead Sciences, Inc. (GILD), AstraZeneca, Novartis AG, Bristol-Myers Squibb Company, Allergan Plc, Novo Nordisk A/S, Boehringer Ingelheim, Pfizer Inc.